Swiss National Bank

Bank

Position in JANX — Janux Therapeutics, Inc.

CIK 1582202 ZURICH, V8

Position in JANX

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$1,071,690

+$7,710 QoQ

Shares Held

77,100

0.0% QoQ

Ownership

0.126%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. JANX ranks #130 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	744,600	$332,493,684
2	REGN	Regeneron Pharmaceuticals, Inc.	303,140	$234,218,089
3	ALNY	Alnylam Pharmaceuticals, Inc.	387,720	$128,284,916
4	INSM	INSMED Inc	625,912	$102,349,130
5	RPRX	Royalty Pharma plc	1,191,100	$57,137,067
6	INCY	Incyte Corp	489,774	$46,097,528
7	RVMD	Revolution Medicines, Inc.	425,431	$41,373,164
8	MRNA	Moderna, Inc.	696,100	$35,361,880

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,071,690	77,100	0.0%	Shares	Sole	2026-05-07
2025-12-31	$1,063,980	77,100	+3.4%	Shares	Sole	2026-02-12
2025-09-30	$1,823,224	74,600	-5.7%	Shares	Sole	2025-11-13
2025-06-30	$1,827,210	79,100	0.0%	Shares	Sole	2025-08-12
2025-03-31	$2,135,700	79,100	0.0%	Shares	Sole	2025-05-12
2024-12-31	$4,235,014	79,100	+94.3%	Shares	Sole	2025-02-10
2024-09-30	$1,849,001	40,700	0.0%	Shares	Sole	2024-11-07
2024-06-30	$1,704,923	40,700	+28.0%	Shares	Sole	2024-08-08
2024-03-31	$1,197,270	31,800	0.0%	Shares	Sole	2024-05-07
2023-12-31	$341,214	31,800	+39.5%	Shares	Sole	2024-02-06
2023-09-30	$229,824	22,800	0.0%	Shares	Sole	2023-11-08
2023-06-30	$270,636	22,800	-15.6%	Shares	Sole	2023-08-09
2023-03-31	$326,700	27,000	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.